Syde: A cutting-edge digital endpoint plaftorm​

Syde platform

More than a device,
Syde is a digital endpoint platform for mobility assessment

Syde DHT: A Comprehensive Solution

The digital health technology (DHT) Syde® provides an end-to-end solution for continuous, real-world assessment of patient movement in clinical studies.

Syde’s wearable sensors continuously capture movement data as patients go about their daily activities. Each night, the sensors are placed on their docking station for battery charging and secure, passive data transfer. This ensures minimal burden on patients and clinical teams while maintaining seamless, high-quality data collection.

Syde provides an end-to-end solution for continuous, real-world assessment of patient movement
Syde is an end-to-end solution for continuous, real-world assessment of patient movement

In real life, the Syde® sensors continuously record data during the day while the patient wears them.
At night, they are placed on their docking station for battery charging and data uploading.

In our servers, the Syde® algorithms use sensor data to reconstruct 3D trajectories and compute stride-level parameters and Syde®-derived clinical variables.
At the time of study data analysis, the variables are presented to sponsor and clinicians for interpretation.
In real life, the Syde® sensors continuously record data during the day while the patient wears them. At night, they are placed on their docking station for battery charging and data uploading.
In our servers, the Syde® algorithms use sensor data to reconstruct 3D trajectories and compute stride-level parameters and Syde®-derived clinical variables.
At the time of study data analysis, the variables are presented to sponsor and clinicians for interpretation.

Once the data is uploaded, Syde’s proprietary algorithms reconstruct 3D trajectories of patient movement to derive clinically meaningful variables.

From passively collected raw sensor data to clinical variables, the Syde platform converts everyday movement into objective, regulatory-grade insights on patient motor function.

Syde DHT: Ready-To-Deploy Digital Endpoint Solution

Each Syde case contains ready-to-use elements to quickly start data collection:

  • 2 wearable sensors
  • A docking station
  • A portable battery for use during weekends and holidays
  • All the required accessories

From Trajectory Reconstruction to Regulatory-Grade Endpoints

Our algorithms transform real-world motor patterns into validated clinical endpoints. Syde supports both upper and lower-limb assessments, including SV95C (Stride Velocity 95th Centile, top ambulation speed), the first digital endpoint qualified by the EMA.

SV95C primary qualification as a primary endpoint for clinical trials in DMD

Human-Centered Design for Robust Motor Data Collection

At Sysnav Healthcare, we recognize that usability is a critical determinant of patient comfort and compliance in clinical research.

Tests for clinical trials should not be a burden on patients, their families, or clinical teams.

Syde was developed in collaboration with patient associations to ensure ergonomic design, ease of operation, and adaptability across heterogeneous patient populations. Its design integrates seamlessly into daily life, minimizing burden while enabling high-quality motor data collection.

Tests for clinical trials should not be a burden on patients, their families, or clinical teams.

Syde was developed in collaboration with patient associations to ensure ergonomic design, ease of operation, and adaptability across heterogeneous patient populations. Its design integrates seamlessly into daily life, minimizing burden while enabling high-quality motor data collection.

Built With Privacy and Security at the Core

We uphold the highest standards of privacy and security while handling medical data:

No location tracking

No microphone

ISO9001, ISO13485, and ISO27001 certified

No personal identifiable information (email, IP address, etc.)

What is Syde: A Guide for Participants

Here is an example of a patient-facing instructional video for participants in a clinical study.

Copyright © 2025 Edgewise Therapeutics, Inc. All Rights Reserved.

Want to learn how we can support your clinical study?

Schedule a meeting with our team to learn more.

FAQ

Answers to common questions about integrating Syde platform into your clinical trial.

Does Syde capture other mobility endpoints apart from SV95C?

Yes. Stride velocity 95th centile (SV95C) is our best-known endpoint because of its regulatory recognition, but the Syde wearable quantifies different meaningful aspects of patient mobility and movement. Much as a holter monitor delivers continuous cardiac data rather than a single pulse reading, Syde reconstructs full, continuous 3D motion from raw sensor data.

This enables measurement of:
  • Stride velocity
  • Stride length
  • Ground contact time
  • Right-to-left asymmetries
  • Stair climbing and descent
  • ...

Syde also captures upper limb function, including effort and movement amplitude across every axis. We believe that mobility can't be reduced to a single metric. Syde is designed to provide a comprehensive picture of how patients move.

Visit our Digital Endpoints page to discover how Syde's full measurement suite can be configured for your clinical trial protocol.
Yes. Normative reference data are available for many disorders and conditions. Digital outcome data have been collected with Syde from healthy controls and from individuals of all ages across a broad range of disorders such as neuromuscular and neurological diseases, skeletal dysplasias and joint diseases. These data originate from natural history studies conducted in collaboration with research partners, as well as from studies sponsored by us.

In many cases, the results can serve as normative data for other studies, enabling sponsors to interpret their own results against an established reference.

Additional information is available in the Publication section of our Digital Endpoints page.
Yes. Syde has undergone rigorous analytical validation against gold-standard optical motion capture systems in more than 20 diseases.

Our validation protocols cover a diverse range of therapeutic areas, including:
  • Neurological disorders: Multiple Sclerosis (MS), Parkinson's disease, ...
  • Neuromuscular and neurodevelopmental conditions: Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), ...
  • Musculoskeletal and orthopedic indications: Knee osteoarthritis, ...

Across these 20+ disease profiles and complex movement scenarios, the Syde platform consistently demonstrates clinical-grade accuracy, achieving 98% correct stride identification and spatial precision within 2 centimeters per stride.

Learn more about our validation work in the Publications section of our Digital Endpoints page.

Standard deployment takes 8 to 12 weeks and includes Syde specific protocol consultation, regulatory documentation preparation, site training, and device shipment. Accelerated timelines are available for urgent trials, and we align with your existing study startup milestones to minimize delays.

We provide periodic data transfers containing validated clinical endpoints in a format compatible with your statistical software. Each delivery includes tailored analyses customized to your protocol requirements, comprehensive quality control reports with patient-level compliance and data completeness metrics, and dedicated support for data interpretation to help your teams understand the endpoint’s clinical significance.

Each study receives a dedicated Study Manager who provides site onboarding and training, real-time compliance monitoring with proactive outreach to sites for adherence issues, technical troubleshooting for sites, device replacement coordination, regular data quality reports. Support is available across time zones to match your global trial footprint, with escalation protocols for urgent technical issues.